Pathstone Family Office, LLC Moderna, Inc. Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 10,404 shares of MRNA stock, worth $383,387. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,404

Previous 4,738 119.59%

Holding current value

$383,387

Previous $575,000 86.78%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $546,259 - $717,372	5,666 Added 119.59%	10,404 $1.07 Million
Q2 2023 Jan 12, 2024	SELL	$118.5 - $160.53 $669,643 - $907,155	-5,651 Reduced 54.32%	4,753 $577,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $104,872 - $142,069	-885 Reduced 15.74%	4,738 $575,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $570,857 - $829,060	-4,208 Reduced 42.8%	5,623 $863,000
Q4 2022 Oct 23, 2023	BUY	$118.38 - $210.04 $579,114 - $1.03 Million	4,892 Added 99.05%	9,831 $1.77 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $287,071 - $509,347	2,425 Added 32.74%	9,831 $1.77 Million
Q3 2022 Oct 23, 2023	BUY	$118.07 - $194.18 $134,599 - $221,365	1,140 Added 30.01%	4,939 $584,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $142,038 - $233,598	1,203 Added 19.39%	7,406 $875,000
Q2 2022 Oct 23, 2023	SELL	$117.13 - $176.59 $109,985 - $165,818	-939 Reduced 19.82%	3,799 $542,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $394,376 - $594,578	3,367 Added 118.72%	6,203 $886,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $82,325 - $153,017	651 Added 29.79%	2,836 $489,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $397,443 - $648,577	-1,760 Reduced 44.61%	2,185 $554,000
Q3 2021 Nov 16, 2021	BUY	$221.9 - $484.47 $191,277 - $417,613	862 Added 27.96%	3,945 $1.52 Million
Q2 2021 Aug 31, 2021	SELL	$129.91 - $234.98 $301,001 - $544,448	-2,317 Reduced 42.91%	3,083 $725,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $565,552 - $963,376	5,180 Added 2354.55%	5,400 $707,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $7,888 - $20,383	120 Added 120.0%	220 $23,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $5,434 - $9,485	100 New	100 $7,000
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $8,901 - $24,000	-300 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$17.78 - $31.58 $5,334 - $9,474	300 New	300 $9,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Moderna, Inc. Transaction History